For example, alterations in sphingolipid metabolism have been detected in AD, with levels of SPHK1 (UniProtKB Q9NYA1) downregulated and, conversely, levels of SPHK2 (UniProtKB Q9NRA0) upregulated [45]. The gene discussed is SPHK1; the disease is Alzheimer disease.